PLoS ONE · 2009 · 87 citations · 33 references
Zinc transporting proteins in beta-cells respond to variations in glucose and zinc levels. ZnT-3, which is pivotal in the development of cellular changes as also seen in type 2 diabetes (e.g. amyloidosis in Alzheimer's disease) but not previously described in beta-cells, is present in this cell type, up-regulated by glucose in a concentration dependent manner and up-regulated by zinc depletion which by contrast decreased ZnT-3 protein levels. Knock-down of the ZnT-3 gene lowers insulin secretion in vitro and affects in vivo glucose metabolism after streptozotocin treatment.
33
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Janet M. Wenzlau, Kirstine Juhl, Liping Yu et al. · Proceedings of the National Academy of Sciences · 2007 · 990 citations · Full text
Metabolic Syndrome, Zinc Transporter Znt8, Microarray Expression Profiling +15